Marcelo Chaves

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Incidence of Autoimmune Myasthenia Gravis in a Health Maintenance Organization in Buenos Aires, Argentina

Mariela Bettini, Marcelo Chaves, Edgardo Cristiano et al. · Neuroepidemiology · 2017 · 24 citations

Life Sciences, Endocrinology, Immunology +11

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki et al. · Journal of the Neurological Sciences · 2019 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Immune-mediated rippling muscle disease and myasthenia gravis

Mariela Bettini, Hernán Gonorazky, Marcelo Chaves et al. · Journal of Neuroimmunology · 2016 · 13 citations

Medicine, Immunology, Pathology +13